PGI19 Costs and Effects of Dual Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C in Germany

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.768
https://www.valueinhealthjournal.com/article/S1098-3015(12)02481-3/fulltext
Title : PGI19 Costs and Effects of Dual Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C in Germany
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02481-3&doi=10.1016/j.jval.2012.08.768
First page : A329
Section Title : Gastrointestinal Disorders
Open access? : No
Section Order : 280
Categories :
Tags :
Regions :
ViH Article Tags :